Dow Up 0.08% Nasdaq Down 0.30%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
69.85 Up 0.25(0.36%) Sep 19, 4:00PM EDT
|After Hours : 69.53 Down 0.32 (0.45%) Sep 19, 4:40PM EDT
Prev Close:69.60
Open:69.75
Bid:66.00 x 100
Ask:74.22 x 200
1y Target Est:83.53
Beta:0.64
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:68.94 - 69.96
52wk Range:55.04 - 84.25
Volume:1,761,113
Avg Vol (3m):1,078,320
Market Cap:10.28B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 0.36%10.28B
FOLDDown 1.34%520.21M
SHPGDown 0.89%50.46B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.30
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback